BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Department of Justice
Federal Trade Commission

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,462,932

« Back to Dashboard

Summary for Patent: 5,462,932

Title: Oral liquid alendronate formulations
Abstract:Disclosed is a therapy protocol for treating and for preventing bone loss in patients who have difficulty in swallowing by administering a liquid formulation of alendronate which can be easily swallowed. Also described are pharmaceutical dosage forms of a syrup, aqueous solution, a solution formed from a reconstituted powder, of alendronate, for carrying out the therapeutic method.
Inventor(s): Brenner; Gerald S. (Norristown, PA), Katdare; Ashok V. (Norristown, PA), Pretzer; Denise (Chesterfield, MO), Whiteford; Donna T. (Brooklyn, NY)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:08/245,289
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound;

No matches for this query

International Patent Family for Patent: 5,462,932

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
CroatiaP950293► Subscribe
Hong Kong1009245► Subscribe
Finland118296► Subscribe
Finland964593► Subscribe
Spain2180646► Subscribe
European Patent Office0759757► Subscribe
Algeria1884► Subscribe
Czech Republic285860► Subscribe
Czech Republic9603367► Subscribe
Germany69527842► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
US Department of Justice
Argus Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: